Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology.
Adrenal insufficiency
Children
Growth
Growth rate
Height
Primay adrenal insufficiency
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
06
09
2022
accepted:
15
10
2022
medline:
31
3
2023
pubmed:
31
10
2022
entrez:
30
10
2022
Statut:
ppublish
Résumé
Primary adrenal insufficiency (PAI) is an endocrine disorder characterized by direct adrenal failure
Identifiants
pubmed: 36309634
doi: 10.1007/s12020-022-03236-z
pii: 10.1007/s12020-022-03236-z
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
E. Charmandari, N.C. Nicolaides, G.P. Chrousos, Adrenal insufficiency. Lancet 383(9935), 2152–2156 (2014)
pubmed: 24503135
doi: 10.1016/S0140-6736(13)61684-0
T. Kirkgoz, T. Guran, Primary adrenal insufficiency in children: Diagnosis and management. Best. Pr. Res Clin. Endocrinol. Metab. 32(4), 397–424 (2018)
doi: 10.1016/j.beem.2018.05.010
M. Minnetti, S. Caiulo, R. Ferrigno et al. Abnormal linear growth in paediatric adrenal diseases: Pathogenesis, prevalence and management. Clin. Endocrinol. (Oxf.) 92(2), 98–108 (2020)
pubmed: 31747461
doi: 10.1111/cen.14131
K. Muthusamy, M.B. Elamin, G. Smushkin et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 95, 4161–4172 (2010)
pubmed: 20823467
doi: 10.1210/jc.2009-2616
G.J. Kahaly, L. Frommer, Polyglandular autoimmune syndromes. J. Endocrinol. Invest 41(1), 91–98 (2018)
pubmed: 28819917
doi: 10.1007/s40618-017-0740-9
D.B. Grant, N.D. Barnes, M.W. Moncrieff et al. Clinical presentation, growth, and pubertal development in Addison’s disease. Arch. Dis. Child 60(10), 925–8 (1985)
pubmed: 4062344
pmcid: 1777515
doi: 10.1136/adc.60.10.925
N. Bratanic, K. Kisand, M. Avbelj Stefanija et al. Clinical, genetic and immunological characteristics of paediatric autoimmune polyglandular syndrome type 1 patients in slovenia. Zdr. Varst. 54(2), 112–8 (2015)
pubmed: 27646917
pmcid: 4820163
A. Zung, G. Andrews-Murray, O. Winqvist et al. Growth hormone deficiency in autoimmune polyglandular syndrome. J. Pediatr. Endocrinol. Metab. 10(1), 69–72 (1997)
pubmed: 9364345
doi: 10.1515/JPEM.1997.10.1.69
L. Ward, J. Paquette, E. Seidman et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J. Clin. Endocrinol. Metab. 84(3), 844–52 (1999)
pubmed: 10084559
A. Franzese, G. Valerio, S. Di Maio et al. Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Endocrinol. Invest 22(1), 66–9 (1999)
pubmed: 10090140
doi: 10.1007/BF03345481
A.S. Al-Herbish, J.D. Bailey, S.W. Kooh, Growth hormone deficiency in autoimmune polyglandular disease type 1. Saudi Med J. 21(8), 765–8 (2000)
pubmed: 11423892
A. Papathanasiou, E. Kousta, V. Skarpa et al. Growth hormone deficiency in a patient with autoimmune polyendocrinopathy type 2. Hormones (Athens) 6(3), 247–50 (2007)
pubmed: 17724010
B.S. Bin-Abbas, M. Faiyaz-Ul-Haque, A.H. Al-Fares et al. Autoimmune polyglandular syndrome type 1 in Saudi children. Saudi Med J. 31(7), 788–92 (2010)
pubmed: 20635013
T. Pun, V. Chandurkar, Growth hormone deficiency, short stature, and juvenile rheumatoid arthritis in a patient with autoimmune polyglandular syndrome type 1: case report and brief review of the literature. ISRN Endocrinol. 2011, 462759 (2011)
pubmed: 22363878
pmcid: 3262651
doi: 10.5402/2011/462759
S. Millar, D. Carson, Clinical phenotypes of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy seen in the Northern Ireland paediatric population over the last 30 years. Ulst. Med J. 81(3), 118–22 (2012)
E.M. Ferre, S.R. Rose, S.D. Rosenzweig et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight 1(13), e88782 (2016)
pubmed: 27588307
pmcid: 5004733
doi: 10.1172/jci.insight.88782
S. Kemp, I.C. Huffnagel, G.E. Linthorst et al. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history. Nat. Rev. Endocrinol. 12(10), 606–15 (2016)
pubmed: 27312864
doi: 10.1038/nrendo.2016.90
M. Engelen, S. Kemp, F. Eichler, Endocrine dysfunction in adrenoleukodystrophy. Handb. Clin. Neurol. 182, 257–267 (2021)
pubmed: 34266597
doi: 10.1016/B978-0-12-819973-2.00018-6
M. Al-Essa, G.S. Dhaunsi, Selective receptor-mediated impairment of growth factor activity in neonatal- and X-linked adrenoleukodystrophy patients. J. Pediatr. Endocrinol. Metab. 32(7), 733–738 (2019)
pubmed: 31194684
doi: 10.1515/jpem-2018-0540
P. Triantafyllou, M. Economou, E. Vlachaki et al. Multiple endocrine disorders associated with adrenomyeloneuropathy and a novel mutation of the ABCD1 gene. Pediatr. Neurol. 50(6), 622–4 (2014)
pubmed: 24685009
doi: 10.1016/j.pediatrneurol.2014.01.027
J.P. Suntharalingham, F. Buonocore, A.J. Duncan et al. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best. Pr. Res Clin. Endocrinol. Metab. 29(4), 607–19 (2015)
doi: 10.1016/j.beem.2015.07.004
L. Lin, W. Gu, G. Ozisik et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (SF1/Ad4BP, NR5A1) in children and adults with primary adrenal failure: ten years’ experience. J. Clin. Endocrinol. Metab. 91(8), 3048–3054 (2006)
pubmed: 16684822
doi: 10.1210/jc.2006-0603
S.B. Seminara, J.C. Achermann, M. Genel et al. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J. Clin. Endocrinol. Metab. 84(12), 4501–9 (1999)
pubmed: 10599709
W.Y. Tsai, Y.C. Tung, Novel deletion mutations of the DAX1 (NR0B1) gene in two Taiwanese families with X-linked adrenal hypoplasia congenita. J. Pediatr. Endocrinol. Metab. 18(10), 991–7 (2005)
pubmed: 16355812
doi: 10.1515/JPEM.2005.18.10.991
A. Balsamo, A. Antelli, L. Baldazzi et al. A new DAX1 gene mutation associated with congenital adrenal hypoplasia and hypogonadotropic hypogonadism. Am. J. Med Genet 135(3), 292–6 (2005)
pubmed: 15884018
doi: 10.1002/ajmg.a.30689
O. Pérez Rodríguez, J.L. Ruibal Francisco, L. Loidi Fernández de Trocóniz,et al. Gene as a cause of adrenal hypoplasia, hypogonadism and short height novel mutation of DAX-1 gene (pGly168fsX17). An Pediatr (Barc) 64(6), 591–4 (2006) .
I. Ahmad, W.F. Paterson, L. Lin et al. A novel missense mutation in DAX-1 with an unusual presentation of X-linked adrenal hypoplasia congenita. Horm. Res 68(1), 32–7 (2007)
pubmed: 17308433
R.M. Mantovani, I.L. Pezzuti, V.M. Dias et al. Identification of a novel mutation in DAX1/NR0B1A gene in two siblings with severe clinical presentation of adrenal hypoplasia congenita. Arq. Bras. Endocrinol. Metab. 53(6), 771–6 (2009)
doi: 10.1590/S0004-27302009000600013
K. García-Malpartida, M. Gómez-Balaguer, E. Solá-Izquierdo et al. A novel mutation in DAX1 (NR0B1) causing X-linked adrenal hypoplasia congenita: clinical, hormonal and genetic analysis. Endocrine 36(2), 275–80 (2009)
pubmed: 19672728
doi: 10.1007/s12020-009-9232-9
C.M. Wu, H.B. Zhang, Q. Zhou et al. Two novel DAX1 gene mutations in Chinese patients with X-linked adrenal hypoplasia congenita: clinical, hormonal and genetic analysis. J. Endocrinol. Invest 34(8), e235–9 (2011)
pubmed: 21270512
C. Battistin, H.C. Menezes Filho, S. Domenice et al. A novel DAX1/NR0B1 mutation in a patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Arq. Bras. Endocrinol. Metab. 56(8), 496–500 (2012)
doi: 10.1590/S0004-27302012000800006
L.E. Calliari, M.N. Rocha, O. Monte et al. Mild adrenal insufficiency due to a NROB1 (DAX1) gene mutation in a boy presenting an association of hypogonadotropic hypogonadism, reduced final height and attention deficit disorder. Arq. Bras. Endocrinol. Metab. 57(7), 562–5 (2013)
doi: 10.1590/S0004-27302013000700011
Z. Zhang, Y. Feng, Ye D, et al. Clinical and molecular genetic analysis of a Chinese family with congenital X-linked adrenal hypoplasia caused by novel mutation 1268delA in the DAX-1 gene. J Zhejiang Univ Sci B (2015)
T. Yu, J. Wang, Y. Yu et al. X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism: Identification and in vitro study of a novel small indel in the NR0B1 gene. Mol. Med Rep. 13(5), 4039–45 (2016)
pubmed: 27035099
doi: 10.3892/mmr.2016.5006
S. Mohan, S. Danda, S. Mathai et al. Novel mutation in the nuclear receptor subfamily 0, group B, member 1 (NR0B1) gene associated with intrafamilial heterogeneity in three boys with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism from India. Natl Med J. India 32(3), 141–143 (2019)
pubmed: 32129306
doi: 10.4103/0970-258X.278692
L. Iughetti, L. Lucaccioni, P. Bruzzi et al. Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report. BMC Med Genet 20(1), 98 (2019)
pubmed: 31164167
pmcid: 6549270
doi: 10.1186/s12881-019-0834-7
R. Bertalan, Z. Bencsik, P. Mezei et al. Novel frameshift mutation of the NR0B1(DAX1) in two tall adult brothers. Mol. Biol. Rep. 46(4), 4599–4604 (2019)
pubmed: 31280422
doi: 10.1007/s11033-019-04688-9
A.M. Al Amer, K.M. Al Rubaya, A.S. Alzahrani, Adrenal hypoplasia congenita in identical twins. Saudi Med J. 40(1), 87–92 (2019)
pubmed: 30617386
doi: 10.15537/smj.2019.1.23337
S.M. Wu, J.Z. Gao, B. He et al. A novel NR0B1 gene mutation causes different phenotypes in two male patients with congenital adrenal hypoplasia. Curr. Med Sci. 40(1), 172–177 (2020)
pubmed: 32166680
doi: 10.1007/s11596-020-2161-9
M.C.C. Vargas, F.S. Moura, C.P. Elias et al. Spontaneous fertility and variable spectrum of reproductive phenotype in a family with adult-onset X-linked adrenal insufficiency harboring a novel DAX-1/NR0B1 mutation. BMC Endocr. Disord. 20(1), 21 (2020)
pubmed: 32028936
pmcid: 7006140
doi: 10.1186/s12902-020-0500-2
Y. Hasegawa, Y. Takahashi, Y. Kezuka et al. Identification and analysis of a novel NR0B1 mutation in late-onset adrenal hypoplasia congenita and hypogonadism. J. Endocr. Soc. 5(2), bvaa176 (2020)
pubmed: 33381670
pmcid: 7757432
doi: 10.1210/jendso/bvaa176
H. Ouyang, B. Chen, N. Wu et al. X-linked congenital adrenal hypoplasia: a case presentation. BMC Endocr. Disord. 21(1), 118 (2021)
pubmed: 34130666
pmcid: 8204446
doi: 10.1186/s12902-021-00785-8
H.S. Choi, A. Kwon, H.W. Chae et al. Identification of a novel point mutation in DAX-1 gene in a patient with adrenal hypoplasia congenita. Ann. Pediatr. Endocrinol. Metab. 26(2), 126–129 (2021)
pubmed: 34218634
pmcid: 8255865
doi: 10.6065/apem.2040088.044
Y.H. Jee, J. Baron, The biology of stature. J. Pediatr. 173, 32–8 (2016)
pubmed: 27025909
pmcid: 4884478
doi: 10.1016/j.jpeds.2016.02.068
A.T. Reutens, J.C. Achermann, M. Ito et al. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J. Clin. Endocrinol. Metab. 84(2), 504–11 (1999)
pubmed: 10022408
O. Engiz, A. Ozön, F. Riepe et al. Growth hormone deficiency due to traumatic brain injury in a patient with X-linked congenital adrenal hypoplasia. Turk. J. Pediatr. 52(3), 312–6 (2010)
pubmed: 20718192
A. Rojek, M. Obara-Moszynska, E. Malecka et al. NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding. J. Appl Genet 54(2), 225–30 (2013)
pubmed: 23378245
doi: 10.1007/s13353-013-0135-3
S.T. Chung, C.H. Chi, M.W. Haymond et al. Infantile growth hormone deficiency and X- linked adrenal hypoplasia congenita. Jacobs J. Pediatr. 1(1), pii: 003 (2015)
C. Suthiworachai, R. Tammachote, C. Srichomthong et al. Identification and functional analysis of six DAX1 mutations in patients with X-linked adrenal hypoplasia congenita. J. Endocr. Soc. 3(1), 171–180 (2018)
pubmed: 30620004
pmcid: 6316980
doi: 10.1210/js.2018-00270
E. Meimaridou, C.R. Hughes, J. Kowalczyk et al. Familial glucocorticoid deficiency: New genes and mechanisms. Mol. Cell Endocrinol. 371(1-2), 195–200 (2013)
pubmed: 23279877
doi: 10.1016/j.mce.2012.12.010
A. Maharaj, A. Maudhoo, L.F. Chan et al. Isolated glucocorticoid deficiency: Genetic causes and animal models. J. Steroid Biochem Mol. Biol. 189, 73–80 (2019)
pubmed: 30817990
doi: 10.1016/j.jsbmb.2019.02.012
S.M. O’Riordan, S.A. Lynch, P.C. Hindmarsh et al. A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. J. Clin. Endocrinol. Metab. 93(7), 2896–9 (2008)
pubmed: 18430777
doi: 10.1210/jc.2008-0034
T.V. Novoselova, L.F. Chan, A.J.L. Clark, Pathophysiology of melanocortin receptors and their accessory proteins. Best. Pr. Res Clin. Endocrinol. Metab. 32(2), 93–106 (2018)
doi: 10.1016/j.beem.2018.02.002
I. Hanukoglu, R. Rapoport, Routes and regulation of NADPH production in steroidogenic mitochondria. Endocr. Res 21(1-2), 231–41 (1995)
pubmed: 7588385
doi: 10.3109/07435809509030439
E. Meimaridou, M. Goldsworthy, V. Chortis et al. NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice. J. Endocrinol. 236(1), 13–28 (2018)
pubmed: 29046340
doi: 10.1530/JOE-16-0638
O. Jazayeri, X. Liu, C.C. van Diemen et al. A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD). Eur. J. Med Genet 58(12), 642–9 (2015)
pubmed: 26548497
doi: 10.1016/j.ejmg.2015.11.001
C. Berndt, C.H. Lillig, A. Holmgren, Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 292(3), H1227–36 (2007)
pubmed: 17172268
doi: 10.1152/ajpheart.01162.2006
F. Roucher-Boulez, D. Mallet-Motak, D. Samara-Boustani et al. NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects. Eur. J. Endocrinol. 175(1), 73–84 (2016)
pubmed: 27129361
doi: 10.1530/EJE-16-0056
M. Lei, The MCM complex: its role in DNA replication and implications for cancer therapy. Curr. Cancer Drug Targets 5(5), 365–80 (2005)
pubmed: 16101384
doi: 10.2174/1568009054629654
C.R. Hughes, L. Guasti, E. Meimaridou et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J. Clin. Invest 122(3), 814–20 (2012)
pubmed: 22354170
pmcid: 3287227
doi: 10.1172/JCI60224
S.R. Lee, J.R. Kim, K.S. Kwon et al. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem. 274(8), 4722–34 (1999)
pubmed: 9988709
doi: 10.1074/jbc.274.8.4722
R. Prasad, L.F. Chan, C.R. Hughes et al. Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J. Clin. Endocrinol. Metab. 99(8), E1556–63 (2014)
pubmed: 24601690
pmcid: 4207928
doi: 10.1210/jc.2013-3844
M. Serra, J.D. Saba, Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv. Enzym. Regul. 50(1), 349–62 (2010)
doi: 10.1016/j.advenzreg.2009.10.024
R. Prasad, I. Hadjidemetriou, A. Maharaj et al. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. J. Clin. Invest 127(3), 942–953 (2017)
pubmed: 28165343
pmcid: 5330744
doi: 10.1172/JCI90171
N. Settas, R. Persky, F.R. Faucz et al. SGPL1 deficiency: a rare cause of primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 104(5), 1484–1490 (2019)
pubmed: 30517686
doi: 10.1210/jc.2018-02238
A.J. Clark, F.M. Cammas, A. Watt et al. Familial glucocorticoid deficiency: one syndrome, but more than one gene. J. Mol. Med (Berl.) 75(6), 394–9 (1997)
pubmed: 9231879
doi: 10.1007/s001090050124
A.J. Clark, A. Weber, Adrenocorticotropin insensitivity syndromes. Endocr. Rev. 19(6), 828–43 (1998)
pubmed: 9861547
doi: 10.1210/edrv.19.6.0351
L.L. Elias, A. Huebner, L.A. Metherell et al. Tall stature in familial glucocorticoid deficiency. Clin. Endocrinol. (Oxf.) 53(4), 423–30 (2000)
pubmed: 11012566
doi: 10.1046/j.1365-2265.2000.01122.x
H. Imamine, H. Mizuno, Y. Sugiyama et al. Possible relationship between elevated plasma ACTH and tall stature in familial glucocorticoid deficiency. Tohoku J. Exp. Med 205(2), 123–31 (2005)
pubmed: 15673970
doi: 10.1620/tjem.205.123
T.T. Chung, L.F. Chan, L.A. Metherell et al. Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin. Endocrinol. (Oxf.) 72(5), 589–94 (2010)
pubmed: 19558534
doi: 10.1111/j.1365-2265.2009.03663.x
L. Akın, S. Kurtoğlu, M. Kendirici et al. Familial glucocorticoid deficiency type 2: a case report. J. Clin. Res Pediatr. Endocrinol. 2(3), 122–5 (2010)
pubmed: 21274326
pmcid: 3005676
doi: 10.4274/jcrpe.v2i3.122
L.S. Bicknell, E.M. Bongers, A. Leitch et al. Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat. Genet 43(4), 356–9 (2011)
pubmed: 21358632
pmcid: 3068194
doi: 10.1038/ng.775
H. Patt, K. Koehler, S. Lodha et al. Phenotype-genotype spectrum of AAA syndrome from Western India and systematic review of literature. Endocr. Connect 6(8), 901–913 (2017)
pubmed: 29180348
pmcid: 5705786
doi: 10.1530/EC-17-0255
V. Sarathi, N.S. Shah, Triple-A syndrome. Adv. Exp. Med Biol. 685, 1–8 (2010)
pubmed: 20687490
doi: 10.1007/978-1-4419-6448-9_1
M. Dumić, A. Radica, Z. Sabol et al. Adrenocorticotropic hormone insensitivity associated with autonomic nervous system disorders. Eur. J. Pediatr. 150(10), 696–9 (1991)
pubmed: 1655458
doi: 10.1007/BF01958757
M. Dumić, N. Barišić, N. Rojnić-Putarek et al. Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy. Eur. J. Pediatr. 170(3), 393–6 (2011)
pubmed: 20931227
doi: 10.1007/s00431-010-1314-4
M. Dumic, N. Barišic, V. Kusec et al. Long-term clinical follow-up and molecular genetic findings in eight patients with triple A syndrome. Eur. J. Pediatr. 171(10), 1453–9 (2012)
pubmed: 22538409
doi: 10.1007/s00431-012-1745-1
E. Kurnaz, P. Duminuco, Z. Aycan et al. Clinical and genetic characterisation of a series of patients with triple A syndrome. Eur. J. Pediatr. 177(3), 363–369 (2018)
pubmed: 29255950
doi: 10.1007/s00431-017-3068-8
R. Polat, A. Ustyol, E. Tuncez et al. A broad range of symptoms in allgrove syndrome: single center experience in Southeast Anatolia. J. Endocrinol. Invest 43(2), 185–196 (2020)
pubmed: 31435881
doi: 10.1007/s40618-019-01099-2
J. Sanghvi, A.A. Asati, R. Kumar et al. Novel mutations in a patient with triple A syndrome. Indian Pediatr. 52(9), 805–6 (2015)
pubmed: 26519721
doi: 10.1007/s13312-015-0722-y
S. Akram, M.A. Khan, A. Rehman, Allgrove syndrome: case report of 7 years old boy from Bahawalpur. J. Pak. Med Assoc. 68(8), 1260–1262 (2018)
pubmed: 30108399
H. Berrani, T. Meskini, M. Zerkaoui et al. Clinical and molecular report of c.1331 + 1G > A mutation of the AAAS gene in a Moroccan family with Allgrove syndrome: a case report. BMC Pediatr. 18(1), 184 (2018)
pubmed: 29866068
pmcid: 5987581
doi: 10.1186/s12887-018-1161-4
K. Koehler, K. Hackmann, D. Landgraf et al. Homozygous deletion of the entire AAAS gene in a triple A syndrome patient. Eur. J. Med Genet 62(7), 103665 (2019)
pubmed: 31071487
doi: 10.1016/j.ejmg.2019.05.004
H. Bustanji, B. Sahar, A. Huebner et al. Triple A syndrome with a novel indel mutation in the AAAS gene and delayed puberty. J. Pediatr. Endocrinol. Metab. 28(7-8), 933–6 (2015)
pubmed: 25781531
doi: 10.1515/jpem-2014-0401
L. Cherif Ben Abdallah, Y. Lakhoua, M. Nagara et al. A Tunisian patient with two rare syndromes: triple a syndrome and congenital hypogonadotropic hypogonadism. Horm. Res Paediatr. 82(5), 338–43 (2014)
pubmed: 25247238
doi: 10.1159/000365888